What is Rx Redefined worth?
$77.0Mlast known valuation
Rx Redefined last raised $21.5M in its Early Stage VC (Dec 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Rx Redefined
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2024 | Early Stage VC | $21.5M | ▮ | ▮ |
| Aug 2022 | Early Stage VC | $8.0M | ▮ | ▮ |
| May 2021 | Seed Round | $3.2M | ▮ | ▮ |
| Jan 2021 | Seed Round | $3.0M | ▮ | ▮ |
How Rx Redefined's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Rx Redefined, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Rx Redefined worth?
- Rx Redefined's last known valuation is $77.0M.
- How much has Rx Redefined raised?
- Rx Redefined has raised $35.6M in total funding across 4 recorded rounds.
- When did Rx Redefined last raise?
- Rx Redefined last raised in Dec 2024 (Early Stage VC), raising $21.5M.